Development and validation of an LC-MS/MS method for the determination of bullatine A in rat plasma: application to a pharmacokinetic study

被引:8
作者
Teng, Shi-Yong [1 ]
Zhang, Si-Xi [2 ]
Niu, Kai [3 ]
Zhai, Li-Jie [4 ]
Wang, Shi-Ji [5 ]
机构
[1] Jilin Univ, Dept Anesthesiol, Hosp 1, Changchun 130021, Peoples R China
[2] Jilin Univ, Dept Pharm, Hosp 1, Changchun 130021, Peoples R China
[3] Jilin Univ, Dept Otorhinolaryngol Head & Neck Surg, Hosp 1, Changchun 130021, Peoples R China
[4] Jilin Univ, Dept Med Management, Hosp 2, Changchun 130041, Peoples R China
[5] Jilin Univ, Dept Crit Care Med, Hosp 1, Changchun 130021, Peoples R China
关键词
bullatine A; pharmacokinetics; LC-MS; MS; rat plasma; ALKALOIDS; ACONITUM;
D O I
10.1002/bmc.3498
中图分类号
Q5 [生物化学];
学科分类号
070307 [化学生物学];
摘要
Bullatine A is a diterpenoid alkaloid of Xue-Shang-Yi-Zhi-Hao (Aconitum brachypodum), which is widely used in traditional Chinese medicine for the treatment of rheumatism and pain. The plasma levels of bullatine A were measured by a rapid and sensitive LC-MS/MS method. Samples were prepared using acetonitrile precipitation and the separation of bullatine A was achieved on a Capcell Pak MG-C-18 column by isocratic elution using acetonitrile (phase A) and 0.1% formic acid (phase B, pH4.0; A:B, 30:70, v/v) as the mobile phase at a flow rate of 0.5mL/min. Detection was performed on a triple-quadrupole tandem mass spectrometer by multiple-reaction monitoring of the transitions at m/z 344.2 105.2 for bullatine A and m/z 256.2 167.1 for the internal standard. The linearity was found to be within the concentration range of 1.32-440ng/mL with a lower limit of quantification of 1.32ng/mL. Only 1.3min was needed for an each analytical run. This method was successfully applied in the determination of the active component bullatine A in rat plasma after intramuscular administration of A. brachypodum injection. Copyright (c) 2015 John Wiley & Sons, Ltd.
引用
收藏
页码:1798 / 1804
页数:7
相关论文
共 16 条
[1]
The effects of Aconitum alkaloids on the central nervous system [J].
Ameri, A .
PROGRESS IN NEUROBIOLOGY, 1998, 56 (02) :211-235
[2]
[Anonymous], 2012, GUIDELINE BIOANALYTI, V44
[3]
China Pharmacopoeia Committee, 1977, PHARM CHINA, P580
[4]
[高绍阳 Gao Shaoyang], 2005, [药物分析杂志, Chinese Journal of Pharmaceutical Analysis], V25, P1382
[5]
[耿家玲 Geng Jialing], 2011, [药物分析杂志, Chinese Journal of Pharmaceutical Analysis], V31, P387
[6]
He YJ, 2009, SHAANXI J TRADITIONA, V30, P1658
[7]
Huang XJ, 2013, J S CENTRAL U NATL, V32, P50
[8]
Huang XJ, 2012, J S CENTRAL U NATL, V31, P36
[9]
Li GN., 1990, YUNNAN ZHIWU ZHI, P472
[10]
Li JH, 2008, CHINESE J INFORM TRA, V15, P59